A broad range of services include:
- Weekly and as-needed meetings
- Review of Phase I-IV biomedical research, single and multiple investigator
- Review of Medical Device research
- Review of Social and behavioral research
- Review of Investigator-sponsored research
- Review of research conducted in academic and hospital settings
- Review of projects that may be exempt from federal regulations
- Review of Transnational research
- Expedited review of studies as identified in the Federal Register
- Revisions and maintenance of approved Informed Consent documents
- Informed Consent composition
- Document translation
IntegReview’s fee schedule is subject to change without notice.
You will be invoiced an additional charge of $210 for late continuing review submissions.
Download our current Fee Schedule (revised 02/01/2012)
Should you have other questions or concerns regarding the IntegReview Services and Fees, please call us at 512-326-3001 or send us an email at integreview@integreview.com.